Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
68 participants
INTERVENTIONAL
2005-11-30
2006-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The World Health Organization (WHO) advises against recumbent or supine position for longer periods during labour and birth and states that caregivers should encourage and support the woman to take the position she finds most comfortable. It has been suggested that upright positions may improve childbirth outcomes and reduce the risk for instrumental delivery.
Objective:
The primary objective was to test the hypothesis that birthing on the "BirthRite" ® seat will result in a reduction in the number of primiparous women delivered instrumentally.
Method:
A power calculation showed (α = 0.05 β = 0.2) a requirement of 460 participants in each of the two arms of the trial in order to test for a 40% reduction (from 15% to 9%) of instrumental deliveries in primiparous women at a maternity unit in southern Sweden. It was decided to subject the study to a feasibility test by conducting a pilot-study in which 68 women were randomised to give birth on the birthing seat or to give birth in any other position but on the "BirthRite" ® seat. Randomization to birth on the birthing seat or in any other position took place when the participant's cervix was fully dilated. The primary outcome measurement was the number of instrumental deliveries. Secondary outcome measurements included oxytocin augmentation, perineal trauma, and blood loss administration of oxytocin for augmentation of labour, length of the second stage of labour, perineal trauma, perineal oedema, maternal blood loss and haemoglobin, apgar scores, cord pH and transfers to the Neonatal Intensive Care Unit(NICU).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Swedish Birth Seat Trial
NCT01182038
A Device Designed to Protect the Perineum During Labor
NCT01533467
Acceptability Assessment of an Optimized Birthing Position
NCT04056793
Fetal Pillow Randomized Controlled Trial
NCT03342508
Room 4 Birth - An Adaptable Birthing Room and the Effect on Labour and Birth
NCT03948815
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
Randomized to give birth on a birthing seat
"BirthRite"
Randomization takes place on admission to delivery unit, study group participants seated on the birthing seat when cervix is fully dilated.
control group
Randomized to birth in any other position except the birthing seat
"BirthRite"
Randomization takes place on admission to delivery unit, study group participants seated on the birthing seat when cervix is fully dilated.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
"BirthRite"
Randomization takes place on admission to delivery unit, study group participants seated on the birthing seat when cervix is fully dilated.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pregnancy must have been normal, with a singleton fetus in cephalic presentation and the onset of labour occurring between gestation weeks 37 + 0 and 41 + 6.
* Women having diet treated pregnancy diabetes were also included.
* Obstetric primiparous women with former caesarean section were included as well as those induced because of premature rupture of membranes (PROM).
Exclusion Criteria
* Primiparous women were excluded in cases of birth before week 36 + 6, breech presentation, maternal BMI over 30, multiple pregnancy or infectious disease.
* Primiparous women with pre-eclampsia or other conditions that require medical care were not eligible for the pilot study.
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stig and Ragna Gorthons foundation
UNKNOWN
Helsingborgs Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Helsingborgs Hospital, Sweden
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claes Lindoff, PhD, MD
Role: STUDY_DIRECTOR
Helsingborgs Hospital
Linda J Kvist, PhD, RM
Role: STUDY_CHAIR
Helsingborgs Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helsingborgs Hospital
Helsingborg, Skåne County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2005/214
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.